Why the study?
Does implantable cardioverter defibrillator therapy provide appropriate therapy for secondary prevention in patients with acquired long QT syndrome?
Population
43 patients with an implantable cardioverter defibrillator after survived cardiac arrest due to an acquired…
Design
Cohort
Follow-up
mean 84 ± 55 months
Authors
Loading...
Appropriate shocks common in acquired LQTS; hypothesis-generating for ICD secondary prevention, needs prospective confirmation.
Does implantable cardioverter defibrillator therapy provide appropriate therapy for secondary prevention in patients with acquired long QT syndrome?
ICD therapy may be beneficial for secondary prevention in patients with acquired long QT syndrome, as appropriate shocks are common during long-term follow-up regardless of structural heart disease.
Mönnig et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: